Edition:
United Kingdom

Corcept Therapeutics Inc (CORT.OQ)

CORT.OQ on NASDAQ Stock Exchange Capital Market

14.23USD
9:00pm BST
Change (% chg)

$-0.09 (-0.63%)
Prev Close
$14.32
Open
$14.33
Day's High
$14.37
Day's Low
$14.16
Volume
145,048
Avg. Vol
384,189
52-wk High
$25.92
52-wk Low
$11.55

Chart for

About

Corcept Therapeutics Incorporated is a pharmaceutical company engaged in the discovery, development and commercialization of drugs for the treatment of severe metabolic, psychiatric and oncologic disorders. The Company is developing mifepristone, a compound that modulates the effects of cortisol by acting as a competitive... (more)

Overall

Beta: 2.07
Market Cap(Mil.): $2,309.91
Shares Outstanding(Mil.): 113.40
Dividend: --
Yield (%): --

Financials

  CORT.OQ Industry Sector
P/E (TTM): 101.94 30.93 32.76
EPS (TTM): 0.20 -- --
ROI: 50.69 15.07 14.61
ROE: 52.76 16.59 16.33

BRIEF-Corcept Therapeutics Reports Qtrly Revenue $57.7 Million

* CORCEPT THERAPEUTICS ANNOUNCES FIRST QUARTER 2018 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

08 May 2018

Competitors

  Price Chg
Novartis AG (NOVN.S) CHF83.18 +1.38
Pfizer Inc. (PFE.N) $43.79 -0.14
Merck & Co., Inc. (MRK.N) $70.65 -0.13
GlaxoSmithKline plc (GSK.L) 1,535.20 +12.40
AstraZeneca plc (AZN.L) 5,793.00 +141.00
Eli Lilly And Co (LLY.N) $105.70 +0.11
Bristol-Myers Squibb Co (BMY.N) $61.82 +0.23
Bristol-Myers Squibb Co (BMYMP.PK) $1,034.45 --

Earnings vs. Estimates